Buchumschlag

Prevalence of inflammatory bowel disease in alcoholic, non-alcoholic and autoimmune pancreatitis: chronisch entzündliche Darmerkrankungen bei Pankreatitis = Prevalence of inflammatory bowel disease in alcoholic, non-alcoholic and autoimmune pancreatitis : inflammatory bowel disease in pancreatitis

Objectives Patients with inflammatory bowel disease (IBD) frequently reveal features of pancreatic inflammation. However, the prevalence of IBD in patients with alcoholic pancreatitis (AP) and nonalcoholic pancreatitis (NAP) has not yet been determined, and the prevalence of IBD in patients with aut...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schneider, Alexander (VerfasserIn) , Hirth, Michael (VerfasserIn) , Weiß, Christel (VerfasserIn) , Weidner, Philip (VerfasserIn) , Antoni, Christoph Helmer (VerfasserIn) , Thomann, Anne K. (VerfasserIn) , Reindl, Wolfgang (VerfasserIn) , Ebert, Matthias (VerfasserIn) , Pfützer, Roland (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Zeitschrift für Gastroenterologie
Year: 2018, Jahrgang: 56, Heft: 5, Pages: 469-478
ISSN:1439-7803
DOI:10.1055/s-0043-123881
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1055/s-0043-123881
Verlag, lizenzpflichtig, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-123881
Volltext
Verfasserangaben:Alexander Schneider, Michael Hirth, Christel Weiss, Philip Weidner, Christoph Antoni, Anne Thomann, Wolfgang Reindl, Matthias P. Ebert, Roland H. Pfützer
Beschreibung
Zusammenfassung:Objectives Patients with inflammatory bowel disease (IBD) frequently reveal features of pancreatic inflammation. However, the prevalence of IBD in patients with alcoholic pancreatitis (AP) and nonalcoholic pancreatitis (NAP) has not yet been determined, and the prevalence of IBD in patients with autoimmune pancreatitis (AiP) from Germany is unknown.- Aims: Thus, we aimed, first, to determine the prevalence of IBD in AP, NAP, and AiP from a tertiary center in Germany and, second, to characterize patients with AiP and IBD. - Methods We performed a retrospective cross-sectional study to determine the prevalence of IBD in patients with different forms of pancreatitis presenting to our clinic. - Results: Compared to the general population and to a control group with viral hepatitis from our clinic, we observed the most significant increase of IBD in patients with AiP (n = 3/28; p Conclusions Immune-mediated mechanisms related to IBD may participate in the development of AiP, especially AiP type 2, and may also increase the risk for the development of other forms of pancreatic inflammation.
Beschreibung:Gesehen am 07.04.2020
Beschreibung:Online Resource
ISSN:1439-7803
DOI:10.1055/s-0043-123881

Ähnliche Einträge